Four manufacturers sign sub-licence agreements with MPP to produce generic versions of Nilotinib for…
In a move that would make certain cancer drugs more accessible and cheaper for patients, the Medicines Patent Pool (MPP) signed sub-licence agreements with three India-based companies, Eugia, Hetero and Dr. Reddy’s Laboratories, along with…